Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium and/or budesonide/formoterol on systemic biomarkers of inflammation in COPD group D
ChiCTR-IPR-14005619Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tiotropium and budesonide in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: C-reactive protein, interleukin-6 and 2 more. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
tiotropiumbudesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-14005619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005619.